Cognitive · Cortical peptide hydrolysate · Compounded 503A
Cortexin: bovine cortical peptide complex.
Cortexin is a low-molecular-weight polypeptide preparation extracted from bovine cerebral cortex. Used clinically in Russia and Eastern Europe for decades, it has been studied for post-stroke recovery, traumatic brain injury, cognitive aging, and pediatric neurology indications. Like Cerebrolysin, it is a pleiotropic neurotrophic preparation rather than a single-molecule drug.
Free shipping over $150 · Pay with card or crypto
What Cortexin is
Cortexin is a standardized preparation of low-molecular-weight peptides (<10 kDa), free amino acids, vitamins and minerals derived from purified bovine cerebral cortex.
Developed in the Soviet Union and approved in Russia and several CIS / Eastern European countries, it is widely used in neurology and pediatric neurology for cognitive, post-stroke, TBI, and developmental indications.
It is not FDA-approved in the United States. Compounded forms are dispensed by licensed 503A pharmacies under physician prescription for off-label use.
How it works
The peptide fractions act as neurotrophic-factor mimetics, supporting neuronal survival, axonal sprouting, and synaptic plasticity.
Additional reported mechanisms include modulation of glutamate/GABA balance, reduction of neuronal oxidative stress, and anti-inflammatory effects on microglia.
The overall signal is pleiotropic — multi-pathway neurotrophic and neuroprotective — comparable conceptually to Cerebrolysin but derived from cortex rather than whole brain.
What patients use it for
Post-stroke recovery
Russian-language RCTs and case series report improved cognitive and motor recovery when added to standard post-stroke care.
Traumatic brain injury
Used in TBI rehabilitation protocols for cognitive and asthenic-syndrome support.
Cognitive aging
Used for age-related cognitive decline and vascular cognitive impairment in approved regions.
Pediatric neurology
Used internationally for developmental delay, epilepsy adjunct, and post-encephalitic syndromes — not an indication kindr addresses.
Evidence summary
The bulk of clinical evidence is Russian-language and not indexed in PubMed at the same density as Western drugs. Several small RCTs and large observational series support efficacy and safety in approved indications.
Mechanism-of-action support comes from preclinical studies showing neurotrophic and anti-oxidative effects.
Western-language reviews characterize the evidence as positive but heterogeneous — similar to early Cerebrolysin literature.
Dosing and clinical context
General clinical context only. Kindr Health physicians determine the appropriate dose and protocol for each patient based on history and labs. This is not a prescription or dosing recommendation.
Intramuscular injection, typically 10 mg/day for adults, in 10-day courses.
Courses are commonly repeated 2–3 times per year depending on indication and clinical response.
Compounded by licensed 503A pharmacies in the U.S.; international branded Cortexin is not imported for U.S. clinical use.
Safety and contraindications
Generally well tolerated. Most-reported issues: transient injection-site reactions and rare allergic responses (porcine/bovine protein origin).
Contraindications: known protein hypersensitivity, pregnancy, lactation, pediatric (off-label in the U.S.).
Not FDA-approved. Off-label compounded use under physician supervision only.
Who it's typically considered for
- Adults in post-stroke or post-TBI recovery (under physician supervision)
- Patients with vascular cognitive impairment pursuing adjunctive support
- Patients with post-concussion syndromes persisting beyond standard recovery
Frequently asked questions
Cortexin vs Cerebrolysin?
Both are brain-derived peptide hydrolysates with overlapping mechanisms. Cortexin is cortex-derived (Russian origin); Cerebrolysin is whole-brain derived (Austrian origin). Cortexin is dosed in shorter, smaller courses.
Is it FDA-approved?
No. It is approved in Russia and several CIS countries. In the U.S. it is compounded under physician prescription for off-label use.
How is it given?
Intramuscular injection, typically once daily for a 10-day course.
How fast does it work?
Most clinical observations are made at the end of a 10-day course; effects on cognition and recovery may build over subsequent weeks.
Is it safe long-term?
Decades of Russian post-marketing data support a favorable safety profile in approved indications.
Sources
- Skoromets AA et al. Cortexin in the complex therapy of cerebrovascular diseases. Zh Nevrol Psikhiatr (Russian, 2009). — pubmed.ncbi.nlm.nih.gov/19838055
- Khavinson VKh. Peptidergic regulation of homeostasis (Khavinson peptide framework, includes cortical peptides). — pubmed.ncbi.nlm.nih.gov/12937526
- Granstrem OK, Diakonov MM. Cortexin: an overview of preclinical and clinical data. Russ J Cardiol (2016, English summary). — pubmed.ncbi.nlm.nih.gov/?term=cortexin
Considering Cortexin?
A Kindr Health physician reviews every longevity intake — peptides are prescribed only when medically indicated based on your history and labs. There is no charge for the initial review.
Related peptides
Medically reviewed by Kindr Health Clinical Team
Kindr Health Inc. — Editorial & Clinical Team (physician-supervised)
NPI 1609792902 · Last reviewed: July 3, 2026
Last reviewed July 3, 2026. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products. Prescriptions require a clinical evaluation; a Kindr Health physician determines eligibility. Not for use in pregnancy. This page provides educational information and is not medical advice.